By Benjamin Chiou
Date: Tuesday 27 May 2025
(Sharecast News) - Life sciences company Avacta Therapeutics has announced that it has had to delay the release of its annual results by a week.
The company, which develops next generation peptide drug conjugates, was originally due to report its results for 2024 on 29 May, but said that auditors have...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news